Concord Biotech IPO GMP, Concord Biotech Grey Market Premium Today
Concord Biotech IPO: Concord Biotech IPO GMP (Concord Biotech Grey Market Premium), Concord Biotech Limited IPO Date, Concord Biotech Ltd IPO Review and Rating for Short term and long-term. We will update Concord Biotech GMP daily. Stay tuned with us for Concord Biotech IPO GMP and other important updates.
Concord Biotech IPO Details
Concord Biotech Ltd Has filed its DRHP (Draft Red Herring Prospectus) with market regulator SEBI (Securities and Exchange Board of India) to raise around Rs 1551 crore through IPO (Initial public offering).
Concord Biotech IPO opening Date is 04 August 2023 and the closing date is 08 August 2023. Concord Biotech IPO Price band is ₹705 to ₹741. Concord Biotech Limited IPO size is 1551 Crores. Concord Biotech IPO QIB quota is 50%, NII quota is 15% and RII quota is 35%. Concord Biotech IPO will list on 18 August 2023. You can know about Concord Biotech IPO GMP (Grey Market Premium) below.
You can also know about Concord Biotech Limited financial details i.e. Total assets, Revenue, and Profit after tax. The company made a profit of ₹240.08 crores in the financial year 2023 (March 2021). The IPO of Concord Biotech will be listed on NSE and BSE. Concord Biotech IPO face value is ₹1 per equity share.
We will talk about Concord Biotech Limited's financials, benefits, and risks of investing in the company. You can see All information about Concord Biotech IPO GMP, Kostak rate, and subject to sauda rates below.
Concord Biotech GMP Today (Grey Market Premium)
| DATE | GMP | KOSTAK | Subject to Sauda |
|---|---|---|---|
| 17 August | ₹122 | ₹- | ₹- |
| 16 August | ₹120 | ₹- | ₹- |
| 15 August | ₹114 | ₹- | ₹- |
| 14 August | ₹120 | ₹- | ₹- |
| 13 August | ₹125 | ₹- | ₹- |
| 12 August | ₹130 | ₹- | ₹- |
| 11 August | ₹145 | ₹- | ₹- |
| 10 August | ₹155 | ₹- | ₹- |
| 09 August | ₹160 | ₹- | ₹- |
| 08 August | ₹155 | ₹- | ₹- |
| 07 August | ₹165 | ₹- | ₹- |
| 06 August | ₹150 | ₹- | ₹- |
| 05 August | ₹150 | ₹- | ₹- |
| 04 August | ₹185 | ₹- | ₹- |
| 03 August | ₹185 | ₹- | ₹- |
Concord Biotech IPO Date and Price Band Details
| IPO Open: | 04 August 2023 |
| IPO Close: | 08 August 2023 |
| Listing Date: | 18 August 2023 |
| Listing On: | NSE & BSE |
| IPO Size: | Approx ₹1551 crores |
| Fresh Issue: | Approx ₹0 crores |
| Offer For Sale: | Approx ₹1551 crores |
| Price Band: | ₹705 to ₹741 per share |
| Face Value: | ₹1 per Equity share |
| QIB Portion: | 50% |
| Retail Portion: | 35% |
| NII Portion: | 15% |
| Employee Res: | Not Disclosed |
Concord Biotech IPO Lot Size Details
| Minimum Lot: | 01 |
| Minimum Lot Size: | 20 Shares |
| Minimum Amount: | ₹14,820 |
| Maximum Lot: | 13 |
| Maximum Lot Size: | 260 Shares |
| Maximum Amount: | ₹192,660 |
Concord Biotech IPO Open, Close, Allotment, and Listing Date
| Ipo Opening Date: | 04 August 2023 |
| IPO Closing Date: | 08 August 2023 |
| Basis of Allotment: | 11 August 2023 |
| Refund Date: | 14 August 2023 |
| Credit to Demat Account: | 17 August 2023 |
| Listing Date: | 18 August 2023 |
Concord Biotech IPO Review
| Happiest Post | Apply |
| Dilip Davda | May Apply |
| Reliance Securities | Apply |
| Axis Capital | Not Rated yet |
| HDFC Securities | Not Rated yet |
| ICICI Direct | Not Rated yet |
| Kotak Securities | Not Rated yet |
| Motilal Oswal | Not Rated yet |
| Sharekhan | Not Rated yet |
You can also check the latest IPO subscription status and IPO allotment status of Concord Biotech IPO on our website.
Promoters
- Sudhir Vaid
- Ankur Vaid
Contact Details of Concord Biotech
NH-8A, Sarkhej- Bavla Highway,
Changodar, Ahmedabad 382213,
Gujarat, India
Telephone: +91 2717-618200
E-mail: sec@harshaengineers.com
Website:www.harshaengineers.com
Concord Biotech Lead Managers
- Kotak Mahindra Capital Company Limited
- Citigroup Global Markets India Private Limited
- Jefferies India Private Limited
Concord Biotech IPO Registrars
C-101, 1st Floor, 247 Park
L.B.S. Marg, Vikhroli (West)
Mumbai 400 083, Maharashtra
Telephone: +91 22 4918 6200
Email: harshaengineers.ipo@linkintime.co.in
Website:www.linkintime.co.in
Conclusion
The GMP (Grey Market Premium), Kostak Rate, and Subject Rate of Concord Biotech IPO are given in the above table. The track record has been good considering the financial position of the company. The company had a profit of Rs 140.08 crore in the financial year 2023. Our suggestion will be updated when Concord Biotech Limited IPO starts. Given above is the brokerage review of Concord Biotech Limited IPO and other information. Click here to know the strength, risk, and financial details of Concord Biotech IPO.
Concord Biotech IPO FAQs
How to Apply the Concord Biotech Ltd IPO with Zerodha?
Disclaimer
- We are not involved in gray market trading in any way. And do not provide the facility to buy or sell any IPO from IPO.
- Reference to IPO Grey Market Premium (IPO GMP) is valid only for the date specified in the header.
- We are not involved in the buying or selling of IPO forms.
- Do not decide to subscribe to an IPO solely based on GMP (Grey Market Premium), as this can change at any time. Research the fundamentals and financial statements of companies before subscribing.
We hope you like this article about Electronics Mart India IPO GMP (Gray Market Premium). If you have a query about Electronics Mart India IPO GMP then, leave a comment. Here you can also stay updated about the IPO Allotment Status and upcoming IPO. Also, you can track IPO performance. You can use our tools Stock Average Calculator, Profit and Loss Calculator, and SIP Calculator for free. Thanks for Visiting. Happy Investing.
0 Comments
We are waiting for your comments. 💙